Gültekin Adanaş Aydın

Dr. Gültekin Adanaş Aydın


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2021 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Open access
PDF file
GAGültekin Adanaş Aydın
Gültekin Adanaş Aydın
SÜSerhat Ünal
Serhat Ünal
HÖHilal Gülsüm Turan Özsoy
Hilal Gülsüm Turan Özsoy
Objective: We aimed to investigate the incidence of adverse pregnancy outcomes including preterm birth, preeclampsia (PE), and fetal growth restriction (FGR) in pregnant women with COVID‐19 according to the gestational age.Methods: This retrospective study included 167 pregnant women who were hospitalized with confirmed COVID‐19. The patients were divided into three groups according to the time of diagnosis as follows: 24 weeks of gestation (n = 129). Medical records of the patients were reviewed retrospectively and adverse pregnancy outcomes were analyzed.Results: A total of 49 (29.3%) patients had an active COVID‐19 infection at the time of delivery, while 118 (70.7%) gave birth after the infection was cleared. Twenty‐three patients had preterm birth and the gestational age was <34 weeks in only four of these patients. There was no significant difference in the preterm birth, PE, FGR, HELLP syndrome, and gestational diabetes mellitus among the three gestation groups (p = 0.271, 0.394, 0.403, 0.763, and 0.664, respectively). Four (2.39%) patients required intensive care unit stay. Maternal death was seen in only one (0.59%) patient.Conclusion: Our study showed no significant correlation between the gestational age at the time of COVID‐19 infection and the frequency of adverse pregnancy outcomes such as preterm birth, PE, FGR, and gestational diabetes mellitus. However, further studies are needed to draw a firm conclusion on this topic.

1 September 2020 in Taiwanese Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
GAGültekin Adanaş Aydın
Gültekin Adanaş Aydın
GÖGülten Özgen
Gülten Özgen
OGOrhan Görükmez
Orhan Görükmez
Intrahepatic cholestasis of pregnancy (ICP) is a liver disorder of pregnancy characterized by pruritus, elevated liver enzymes and fasting serum bile acids. Genetic predisposition has been suggested to play a role in its etiology and mutations in the ATP8B1(OMIM ∗602397) (FIC1), ABCB11(OMIM ∗603201) (BSEP), and ABCB4(OMIM ∗171060) (MDR3) genes have been implicated. In the present study, we aimed to investigate the possible role of ATP8B1, ABCB11, and ABCB4 gene mutations in the patients with ICP. A total of 25 patients who were diagnosed with ICP were included in the study. Genetic test results and mutation status of the patients as assessed by the next-generation sequencing technology were retrospectively retrieved from the hospital database. Of all patients, significant alterations in the ATP8B1 (n = 2), ABCB11 (n = 1), and ABCB4 (n = 7) genes were observed in 10 patients using the molecular analysis testing. All these alterations were heterozygous. Of these alterations, four were reported in the literature previously, while six were not. Using the in-silico parameters, there was a pathogenic alteration in the ABCB4 gene in one patient, while there was no clinically relevant alteration in the other gene mutations in the remaining nine patients. Considering the fact that the alterations were compatible with clinical presentations of the ICP patients and the incidence of these mutations is low in the general population, we believe that our study results are clinically relevant. Further molecular genetic tests in ICP patients and functional studies supporting the results would shed light into the clinical importance of these alterations.

22 January 2020 in Taiwanese Journal of Obstetrics and Gynecology
Verified
Journal Article
Open access
PDF file
GAGültekin Adanaş Aydın
Gültekin Adanaş Aydın
HÖHilal Gülsüm Turan Özsoy
Hilal Gülsüm Turan Özsoy
HAHandan Ankaralı
Handan Ankaralı
GÖGülten Özgen
Gülten Özgen
SNSalim Neşelioğlu
Salim Neşelioğlu
Objective: Polycystic ovary syndrome (PCOS) is a common hormonal disorder among women of reproductive age characterized by irregular menstruation and hirsutism and is associated with an increased risk for cardiovascular diseases. Increased inflammatory response and oxidative stress may also present in these patients. In this study, we aimed to compare the neutrophil-to-lymphocyte ratio (NLR), mean platelet volume (MPV), and dynamic thiol-disulphide homeostasis (dTDH) between the patients with PCOS and healthy individuals and to investigate the correlation between these parameters and cardiovascular risk factors in patients with PCOS. Materials and methods A total of 60 participants were included in this study. The patient group consisted of 36 patients who were diagnosed with PCOS and the control group consisted of 24 healthy individuals without PCOS. Complete blood count and hormonal tests were performed using blood samples. The NLR, MPV, and dTDH were compared between the patient and control groups. Results: There was no statistically significant difference in the native thiol, total thiol, disulphide levels and disulfide/native, disulfide/total and native/total thiol ratios between the patient and control groups (p = 0.494, p = 0.446, p = 0.338, p = 0.717, p = 0.723, and p = 0.717, respectively). In addition, there was no statistically significant difference in NLR and MPV between the groups (p = 0.531 and p = 0.196). Conclusion: Our study results showed no significant difference in the NLR, MPV, dTDH levels, and inflammatory biomarkers including leukocyte count between the PCOS patients and healthy controls. Based on these findings, we conclude that the diagnosis of PCOS alone in overweight patients has no considerable effect on these biomarkers.

30 August 2019 in Journal of Obstetrics and Gynaecology
Verified
Journal Article
Closed access
GAGültekin Adanaş Aydın
Gültekin Adanaş Aydın
HTHabibe Ayvacı Taşan
Habibe Ayvacı Taşan
NTNazan Tarhan
Nazan Tarhan
EÇErbil Çakar
Erbil Çakar
NGNilgün Şenol Güler
Nilgün Şenol Güler
BTBülent Tandoğan
Bülent Tandoğan
Gestational diabetes mellitus (GDM) is a common complication during pregnancy. Evaluation of the quantitative physical activity in diabetic pregnant women is critical. The aim of this study was to test the reliability and validity of the Pregnancy Physical Activity Questionnaire (PPAQ) in Turkish patients with GDM. A total of 120 pregnant women between the ages of 18 and 44 years with GDM were included. The reliability of the questionnaire was measured by internal consistency and analysis of 2-week test-retest reliability. Of the patients, 74 completed the test-retest procedure. Concurrent validity was examined by comparing the PPAQ with the Short Form of the International Physical Activity Questionnaire (IPAQ) in 36 patients. Test-retest intraclass correlation coefficient scores varied between 0.72 and 0.95. The Spearman rank correlation analysis showed that the PPAQ total activity values were statistically significantly correlated with the total values of IPAQ-Short Form (r = 0.410 and p = .030). In conclusion, the Turkish version of the PPAQ is a valid and reliable tool for the measurement of the physical activity level of pregnant women with GDM.

17 June 2021 in Journal of Obstetrics and Gynaecology Research
Verified
Journal Article
Closed access
PDF file
GAGültekin Adanaş Aydın
Gültekin Adanaş Aydın
HÖHilal G. T. Özsoy
Hilal G. T. Özsoy
PAPınar Ö. Akdur
Pınar Ö. Akdur
GÖGülten Özgen
Gülten Özgen

3 September 2020 in The European Research Journal
Verified
Journal Article
Open access
PDF file
GAGültekin Adanaş Aydın
Gültekin Adanaş Aydın
HÖHilal Gülsüm Turan Özsoy
Hilal Gülsüm Turan Özsoy
Objectives: Polycystic ovary syndrome is a reproductive endocrinopathy, predominantly accompanied by insulin resistance, obesity, and metabolic disorder. In this study, we aimed to investigate the possible relationship between prolactin and adipose tissue and metabolic parameters in patients with polycystic ovary syndrome (PCOS). Methods: A total of 58 patients with PCOS and 34 body mass index (BMI)-matched healthy controls between September 2018 and March 2019 were included in the study. Visceral and subcutaneous adipose tissues were measured using ultrasonography. Serum prolactin, fasting blood glucose, insulin, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglyceride, total cholesterol, luteinizing hormone (LH), total testosterone, dehydroepiandrosterone sulfate (DHEA-S), and 17-hydroxyprogesterone (17-OHP) levels were measured. Results: The median BMI (p = 0.001), waist circumference (p = 0.002), hip circumference (p = 0.003), waist-to-hip ratio (p = 0.013), LH (p = 0.012), total testosterone (p = 0.004), DHEA-S (p = 0.049), 17-OHP (p = 0.001), insulin (p = 0.001), minimum preperitoneal fat thickness (p = 0.001), maximum preperitoneal fat thickness (p = 0.048), and intraperitoneal fat thickness (p = 0.018) were significantly higher in the PCOS group compared to the control group. However, there was no significant correlation between prolactin levels and adipose tissue parameters and insulin levels in the patients with PCOS. Conclusions: Although there was an increase in the preperitoneal and intraperitoneal fat thickness in the PCOS group compared to the control group, no significant correlation was observed between prolactin and visceral and subcutaneous adipose tissues and metabolic parameters.